Biotechnology News

Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026 Chris Rabbat succédera à Fabio Cataldi au poste de Directeur médical (« Chief Medical...

On World Alzheimer’s Day, Swedish biotech Alzinova highlights progress in Alzheimer’s treatment and diagnostics as ALZ-101 enters Phase II start-up.

CAMBRIDGE, Mass., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or...

Please read the announcement in PDF Attachment 2026_18_Share_buyback ...

SYDNEY, AUSTRALIA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune...

PHILADELPHIA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided, biotech/life sciences company focused on advancing novel and...

Vironexis announces complete and durable responses in relapsed/refractory ALL patients treated with VNX-101

REDWOOD CITY, Calif., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced...

BOSTON, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...

HMNC recently closed a $50 million Series B financing and a European commercialization partnership with MEDICE for its Ketabon programDoebler has helped shape HMNC's development since 2019, most...